The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Management of high, moderate, and low penetrance ovarian cancer susceptibility gene mutations: An assessment of current practice patterns.
 
Catherine H. Watson
No Relationships to Disclose
 
Brittany Anne Davidson
Honoraria - EMD Serono
 
Laura Jean Havrilesky
Employment - BIOVENTUS (I)
Research Funding - AstraZeneca; Tesaro
 
Paula S. Lee
No Relationships to Disclose
 
Leah McNally
No Relationships to Disclose
 
Haley Moss
No Relationships to Disclose
 
Rebecca A. Previs
No Relationships to Disclose
 
Allison Puechl
No Relationships to Disclose
 
Angeles Alvarez Secord
Honoraria - Alexion Pharmaceuticals; Aravive; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Merck; Mersana; Myriad Pharmaceuticals; Oncoquest; Tesaro
Consulting or Advisory Role - Alexion Pharmaceuticals; Aravive; Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche; Janssen; Merck; Mersana; Myriad Genetics; Oncoquest; Tesaro
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Genentech (Inst); Merck (Inst); PharmaMar (Inst); Prima BioMed (Inst); TapImmune Inc. (Inst); Tesaro (Inst)
 
Andrew Berchuck
Honoraria - Clovis Oncology; Merck; Tesaro
Research Funding - Novadaq Technologies
Travel, Accommodations, Expenses - Merck
 
Noah D. Kauff
Honoraria - BGI
Consulting or Advisory Role - AstraZeneca; Merck